tissue microarray (tma) blocks (SuperBioChips)
Structured Review

Tissue Microarray (Tma) Blocks, supplied by SuperBioChips, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tissue microarray (tma) blocks/product/SuperBioChips
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer"
Article Title: Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer
Journal: ESMO Open
doi: 10.1016/j.esmoop.2024.104000
Figure Legend Snippet: Schematic of the study design. TMA construction (four cores in each case) was carried out in 286 surgically resected samples, and whole-section slides were used in 114 biopsy samples. Among 286 surgically resected samples, immunohistochemistry on whole-section slides was additionally done in 85 cases to compare between TMA and whole-section slides. CLDN18.2, claudin 18.2; GC, gastric cancer; TMA, tissue microarray.
Techniques Used: Immunohistochemistry, Microarray
Figure Legend Snippet: CLDN18.2 positivity in individual TMA cores and intratumoral heterogeneity. (A) CLDN18.2 positivity rates in each single TMA core (cores A, B, C, and D), as well as the positivity rate in at least one of these cores (positive in ≥1 core). (B) The results of CLDN18.2 immunohistochemistry in 111 cases where CLDN18.2 was positive in at least one core. Homogeneous positivity in all four TMA cores was observed in 43 cases (38.7%) and heterogeneous positivity (different results between TMA cores) occurred in the remaining 68 cases (61.3%). CLDN18.2, claudin 18.2; TMA, tissue microarray.
Techniques Used: Immunohistochemistry, Microarray